Mayne Pharma GroupMYX 
$3.132.89%24h
2.89%24h
Global rank15467
Market cap$257.41M
Change 7d-4.34%
YTD Performance-24.72%
SP500 benchmarkUnderperform
P/E0
P/S2.09
Revenue$123.39M
Earnings$79.26M
Dividend yield-
Main Sector
Healthcare
Category
Mayne Pharma Group MYX Total Debt
MYX Total Debt in 2022: $22.38M
According to Mayne Pharma Group latest financial reports the total debt is $22.38M, an increase of 483.08% to 2022. At the end of 2022 company had $3.84M total debt. This figure represents the debts and financial obligations that Mayne Pharma Group combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Mayne Pharma Group MYX Total Debt History from 2023 to 2022
-
Value:-
MYX Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $22.38M | 483.08% |
| 2022 | $3.84M | -98.06% |
| 2021 | $198.07M | -17.11% |
| 2020 | $238.96M | 10.90% |
| 2019 | $215.48M | - |
View the Top Total Debt Stocks 
